|

Egyptian Hypertrophic Cardiomyopathy Program

RECRUITINGSponsored by Magdi Yacoub Heart Foundation
Actively Recruiting
SponsorMagdi Yacoub Heart Foundation
Started2014-01-01
Est. completion2030-01-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05884892

Summary

Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* All patients diagnosed with hypertrophic cardiomyopathy (index patients) who are willing and consented to participate in the registry.
* All family members of index patients who are willing and consented to participate in the registry.

Exclusion Criteria:

* Refusal to consent to participate in the registry program.

Conditions2

Heart DiseaseHypertrophic Cardiomyopathy

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.